1. Home
  2. CDE vs AMRX Comparison

CDE vs AMRX Comparison

Compare CDE & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDE
  • AMRX
  • Stock Information
  • Founded
  • CDE 1928
  • AMRX 2002
  • Country
  • CDE United States
  • AMRX United States
  • Employees
  • CDE N/A
  • AMRX N/A
  • Industry
  • CDE Precious Metals
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDE Basic Materials
  • AMRX Health Care
  • Exchange
  • CDE Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • CDE 2.5B
  • AMRX 2.4B
  • IPO Year
  • CDE N/A
  • AMRX N/A
  • Fundamental
  • Price
  • CDE $6.03
  • AMRX $7.36
  • Analyst Decision
  • CDE Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • CDE 4
  • AMRX 5
  • Target Price
  • CDE $8.00
  • AMRX $10.80
  • AVG Volume (30 Days)
  • CDE 19.5M
  • AMRX 2.0M
  • Earning Date
  • CDE 05-07-2025
  • AMRX 05-02-2025
  • Dividend Yield
  • CDE N/A
  • AMRX N/A
  • EPS Growth
  • CDE N/A
  • AMRX N/A
  • EPS
  • CDE 0.15
  • AMRX N/A
  • Revenue
  • CDE $1,054,006,000.00
  • AMRX $2,793,957,000.00
  • Revenue This Year
  • CDE $49.05
  • AMRX $10.49
  • Revenue Next Year
  • CDE $10.38
  • AMRX $7.00
  • P/E Ratio
  • CDE $40.20
  • AMRX N/A
  • Revenue Growth
  • CDE 28.35
  • AMRX 16.73
  • 52 Week Low
  • CDE $4.03
  • AMRX $5.18
  • 52 Week High
  • CDE $7.72
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • CDE 53.07
  • AMRX 40.90
  • Support Level
  • CDE $5.69
  • AMRX $6.69
  • Resistance Level
  • CDE $6.51
  • AMRX $7.29
  • Average True Range (ATR)
  • CDE 0.45
  • AMRX 0.39
  • MACD
  • CDE 0.08
  • AMRX -0.04
  • Stochastic Oscillator
  • CDE 75.13
  • AMRX 35.71

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: